Ameriprise
IMRX icon

Ameriprise’s Immuneering IMRX Stock Holding History

Ameriprise’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
+71,454
New +$361K ﹤0.01% 3768
2025
Q4 		– Sell
-47,299
Closed -$331K – 4142
2025
Q3 		$331K Buy
+47,299
New +$245K ﹤0.01% 3766

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Ameriprise's IMRX Position: Q2 2026 in Review

Ameriprise opened a new position in Immuneering (IMRX) in Q2 2026: 71,454 shares worth $357K. The stake represents ﹤0.01% of the portfolio and ranks #3768 among its holdings. This is a return to the name: Ameriprise previously reported a position in IMRX as recently as Q3 2025.

Ameriprise first reported a position in IMRX in Q3 2025 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Ameriprise held 71,454 shares of Immuneering worth $357K as of Q2 2026.
  • Immuneering was a new Ameriprise position in Q2 2026.
  • Immuneering made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3768 holding.
  • Ameriprise first reported a position in Immuneering in Q3 2025 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.